Jinxin Fertility Group (HKG:1951) Will Want To Turn Around Its Return Trends

Simply Wall StDec 9 22:21 ET

The U.S. bioterrorism law has undergone significant changes, the CRO concept has launched a major counterattack, and WuXi AppTec is excited!

Industry pessimistic expectations may improve.

Gelonghui FinanceDec 8 23:10 ET

How to break through the challenges in the development of innovative drugs? The industry suggests focusing on internationalization.

① The year 2024 will be the inaugural year of large-scale authorized trade, and going abroad has become an important direction for the development of local pharmaceutical companies; ② Chinese企业品牌, clinical trial capabilities, data presentation formats, and levels of international operation still need time and practical verification.

cls.cnDec 8 03:48 ET

The Five-year Shareholder Returns and Company Earnings Persist Lower as Jinxin Fertility Group (HKG:1951) Stock Falls a Further 7.7% in Past Week

Simply Wall StNov 18 21:57 ET

Does Jinxin Fertility Group (HKG:1951) Have A Healthy Balance Sheet?

Simply Wall StOct 28 22:01 ET

Jinxin Fertility Group Limited's (HKG:1951) Market Cap Surged HK$2.1b Last Week, Retail Investors Who Have a Lot Riding on the Company Were Rewarded

Simply Wall StOct 7 20:37 ET